Site icon pharmaceutical daily

Innovations in Digital Health, Biomanufacturing, Biopharmaceuticals, Genomics, and Diagnostics, 2019 Study – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Innovations
in Digital Health, Biomanufacturing, Biopharmaceuticals, Genomics, and
Diagnostics”
report has been added to ResearchAndMarkets.com’s
offering.

The Life Science, Health & Wellness TechVision Opportunity Engine (TOE)
covers innovations and new developments across global digital health,
biomanufacturing, pharmaceutical, biological, genomic and diagnostic
landscapes. This TOE also analyzes research advances across
immune-oncology and depression.

The Life Science, Health & Wellness TOE will feature disruptive
technology advances in the global life sciences industry. The
technologies and innovations profiled will encompass developments across
genetic engineering, drug discovery, and development, biomarkers, tissue
engineering, synthetic biology, microbiome, disease management, as well
as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas
including genetic engineering, regenerative medicine, drug discovery and
development, nanomedicine, nutrition, cosmetic procedures, pain and
disease management and therapies, drug delivery, personalized medicine,
and smart healthcare.

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/cbi04d

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Genomics,
E-Healthcare,
Biopharmaceuticals

Exit mobile version